Maternal Multiple Sclerosis and Health Outcomes Among the Children: A Systematic Review

References

• Sevelsted A, Chawes B, Stokholm J, Bonnelykke K, Bisgaard H. Time trends of chronic immune diseases by year of birth in Danish registries. Eur J Epidemiol. 2021;36:1179–1185. doi:10.1007/s10654-021-00804-x
   PubMed Web of Science ®Google Scholar
• Koch-Henriksen N, Magyari M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nat Rev Neurol. 2021;17:676–688. doi:10.1038/s41582-021-00556-y
   PubMed Web of Science ®Google Scholar
• Moberg JY, Laursen B, Thygesen LC, Magyari M. Reproductive history of the Danish multiple sclerosis population: a register-based study. Mult Scler. 2020;26:902–911. doi:10.1177/1352458519851245
   PubMedGoogle Scholar
• Jolving LR, Larsen MD, Fedder J, Norgard BM. Live birth in women with multiple sclerosis receiving assisted reproduction. Reprod Biomed Online. 2020;40:711–718. doi:10.1016/j.rbmo.2020.01.013
   PubMed Web of Science ®Google Scholar
• Lopez-Reyes L, Guio-Sanchez C, Gonzalez-Uribe C, Cardenas-Robledo S. Fertility preferences and unmet need for family planning in women with multiple sclerosis. Front Neurol. 2022;13:1035596. doi:10.3389/fneur.2022.1035596
   PubMed Web of Science ®Google Scholar
• Sadovnick AD, Baird PA. The familial nature of multiple sclerosis: age-corrected empiric recurrence risks for children and siblings of patients. Neurology. 1988;38:990–991. doi:10.1212/WNL.38.6.990
   PubMed Web of Science ®Google Scholar
• Sadovnick AD, Ebers GC, Dyment DA, Risch NJ; The Canadian Collaborative Study Group. Evidence for genetic basis of multiple sclerosis. Lancet. 1996;347:1728–1730. doi:10.1016/S0140-6736(96)90807-7
   PubMed Web of Science ®Google Scholar
• Robertson NP, O’Riordan JI, Chataway J, et al. Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet. 1997;349:1587–1590. doi:10.1016/S0140-6736(96)07317-5
   PubMed Web of Science ®Google Scholar
• Xia Z, White CC, Owen EK, et al. Genes and Environment in Multiple Sclerosis project: a platform to investigate multiple sclerosis risk. Ann Neurol. 2016;79:178–189. doi:10.1002/ana.24560
   PubMed Web of Science ®Google Scholar
• O’Gorman C, Lin R, Stankovich J, Broadley SA. Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology. 2013;40:1–12. doi:10.1159/000341902
   PubMed Web of Science ®Google Scholar
• Dahl J, Myhr KM, Daltveit AK, Hoff JM, Gilhus NE. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology. 2005;65:1961–1963. doi:10.1212/01.wnl.0000188898.02018.95
   PubMed Web of Science ®Google Scholar
• Chen YH, Lin HL, Lin HC. Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population-based study. Mult Scler. 2009;15:606–612. doi:10.1177/1352458508101937
   PubMed Web of Science ®Google Scholar
• Soler B, Ciampi E, Uribe-San-Martin R, et al. Pregnancy outcomes in women with multiple sclerosis. Mult Scler Relat Disord. 2021;48:102682. doi:10.1016/j.msard.2020.102682
   PubMed Web of Science ®Google Scholar
• MacDonald SC, McElrath TF, Hernandez-Diaz S. Pregnancy outcomes in women with multiple sclerosis. Am J Epidemiol. 2019;188:57–66. doi:10.1093/aje/kwy197
   PubMed Web of Science ®Google Scholar
• Coyle PK, Oh J, Magyari M, Oreja-Guevara C, Houtchens M. Management strategies for female patients of reproductive potential with multiple sclerosis: an evidence-based review. Mult Scler Relat Disord. 2019;32:54–63. doi:10.1016/j.msard.2019.04.003
   PubMed Web of Science ®Google Scholar
• Bove RM, Houtchens MK. Pregnancy management in multiple sclerosis and other demyelinating diseases. Continuum. 2022;28:12–33. doi:10.1212/CON.0000000000001108
   PubMedGoogle Scholar
• Siracusano M, Carloni E, Riccioni A, et al. Maternal multiple sclerosis and offspring’s cognitive and behavioral development: what do we know until now? Children. 2022;9:1. doi:10.3390/children9111716
   Google Scholar
• Andersen JB, Sellebjerg F, Magyari M. Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis. Eur J Neurol. 2023;30:162–171. doi:10.1111/ene.15559
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121–127. doi:10.1002/ana.1032
   PubMed Web of Science ®Google Scholar
• Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996;85:843–848. doi:10.1111/j.1651-2227.1996.tb14164.x
   PubMed Web of Science ®Google Scholar
• Lopez-Leon S, Geissbuhler Y, Sabido M, Turkson M, Wahlich C, Morris JK. A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project. J Neurol. 2020;267:2721–2731. doi:10.1007/s00415-020-09913-1
   PubMed Web of Science ®Google Scholar
• Simone IL, Tortorella C, Ghirelli A. Influence of pregnancy in multiple sclerosis and impact of disease-modifying therapies. Front Neurol. 2021;12:697974. doi:10.3389/fneur.2021.697974
   PubMed Web of Science ®Google Scholar
• D’Andrea E, Vinals L, Patorno E, et al. How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools. BMJ Open. 2021;11:e043961. doi:10.1136/bmjopen-2020-043961
   PubMedGoogle Scholar
• Andersen JB, Kopp TI, Sellebjerg F, Magyari M. Pregnancy-Related and perinatal outcomes in women with multiple sclerosis: a nationwide Danish cross-sectional study. Neurol Clin Pract. 2021;11:280–290. doi:10.1212/CPJ.0000000000001035
   PubMedGoogle Scholar
• Dahl J, Myhr KM, Daltveit AK, Gilhus NE. Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. J Neurol. 2008;255:623–627. doi:10.1007/s00415-008-0757-2
   PubMed Web of Science ®Google Scholar
• Strom MS, Tollanes MC, Wilcox AJ, Lie RT, Forthun I, Moster D. Maternal chronic conditions and risk of cerebral palsy in offspring: a national cohort study. Pediatrics. 2021;147:1. doi:10.1542/peds.2020-1137
   Web of Science ®Google Scholar
• Korjagina M, Hakkarainen KM, Burkill S, et al. Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden. Mult Scler Relat Disord. 2021;48:102694. doi:10.1016/j.msard.2020.102694
   PubMed Web of Science ®Google Scholar
• Herbstritt S, Langer-Gould A, Rockhoff M, et al. Glatiramer acetate during early pregnancy: a prospective cohort study. Mult Scler. 2016;22:810–816. doi:10.1177/1352458515623366
   PubMed Web of Science ®Google Scholar
• Thiel S, Langer-Gould A, Rockhoff M, et al. Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German multiple sclerosis and pregnancy registry. Mult Scler. 2016;22:801–809. doi:10.1177/1352458516634872
   PubMed Web of Science ®Google Scholar
• Amato MP, Portaccio E, Ghezzi A, et al. Pregnancy and fetal outcomes after interferon-beta exposure in multiple sclerosis. Neurology. 2010;75:1794–1802. doi:10.1212/WNL.0b013e3181fd62bb
   PubMed Web of Science ®Google Scholar
• Portaccio E, Annovazzi P, Ghezzi A, et al. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: fetal risks. Neurology. 2018;90:e823–e31. doi:10.1212/WNL.0000000000005067
   PubMed Web of Science ®Google Scholar
• Goldacre A, Pakpoor J, Goldacre M. Perinatal characteristics and obstetric complications in mothers with multiple sclerosis: record-linkage study. Mult Scler Relat Disord. 2017;12:4–8. doi:10.1016/j.msard.2016.11.011
   PubMed Web of Science ®Google Scholar
• Razaz N, Joseph KS, Boyce WT, et al. Children of chronically ill parents: relationship between parental multiple sclerosis and childhood developmental health. Mult Scler. 2016;22(11):1452–1462. doi:10.1177/1352458515621624
   PubMed Web of Science ®Google Scholar
• Razaz N, Tremlett H, Boyce T, Guhn M, Marrie RA, Joseph KS. Incidence of mood or anxiety disorders in children of parents with multiple sclerosis. Paediatr Perinat Epidemiol. 2016;30(4):356–366. doi:10.1111/ppe.12290
   PubMed Web of Science ®Google Scholar
• MacDonald SC, McElrath TF, Hernández‐Díaz S. Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis. Pharmacoepidemiol Drug Saf. 2019;28(4):556–560. doi:10.1002/pds.4735
   PubMed Web of Science ®Google Scholar
• Mueller BA, Zhang J, Critchlow CW. Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am J Obstet Gynecol. 2002;186(3):446–452. doi:10.1067/mob.2002.120502
   PubMed Web of Science ®Google Scholar
• Weber-Schoendorfer C, Schaefer C. Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Mult Scler. 2009;15(9):1037–1042. doi:10.1177/1352458509106543
   PubMed Web of Science ®Google Scholar
• Fong A, Chau CT, Quant C, Duffy J, Pan D, Ogunyemi DA. Multiple sclerosis in pregnancy: prevalence, sociodemographic features, and obstetrical outcomes. J Matern Fetal Neonatal Med. 2018;31(3):382–387. doi:10.1080/14767058.2017.1286314
   PubMed Web of Science ®Google Scholar
• Andersen JB, Wandall-Holm MF, Magyari M. Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population. Mult Scler Relat Disord. 2022;59:103529. doi:10.1016/j.msard.2022.103529
   PubMed Web of Science ®Google Scholar
• Andersen JB, Moberg JY, Niclasen J, Laursen B, Magyari M. Mental health among children of mothers with multiple sclerosis: a Danish cohort and register-based study. Brain Behav. 2018;8(10):e01098. doi:10.1002/brb3.1098
   PubMed Web of Science ®Google Scholar
• Barker DJ. The origins of the developmental origins theory. J Intern Med. 2007;261(5):412–417. doi:10.1111/j.1365-2796.2007.01809.x
   PubMed Web of Science ®Google Scholar
• Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359(9313):1221–1231. doi:10.1016/S0140-6736(02)08220-X
   PubMed Web of Science ®Google Scholar
• Tillaut H, Degremont A, Kerbrat S, et al. Pregnancy in women with multiple sclerosis in France from 2010 to 2015: incidence, outcomes, and exposure to disease-modifying therapies. Mult Scler. 2022;28(5):778–789. doi:10.1177/13524585211035376
   PubMed Web of Science ®Google Scholar
• Marozio L, Cavalla P, Sottemano S, et al. Fetal and post-natal growth in infants of mothers with multiple sclerosis: a case-control stud. Mult Scler Relat Disord. 2022;65:104087. doi:10.1016/j.msard.2022.104087
   PubMed Web of Science ®Google Scholar
• Moberg JY, Magyari M, Koch-Henriksen N, Thygesen LC, Laursen B, Soelberg Sorensen P. Educational achievements of children of parents with multiple sclerosis: a nationwide register-based cohort study. J Neurol. 2016;263(11):2229–2237. doi:10.1007/s00415-016-8255-4
   PubMed Web of Science ®Google Scholar
• Diareme S, Tsiantis J, Kolaitis G, et al. Emotional and behavioural difficulties in children of parents with multiple sclerosis: a controlled study in Greece. Eur Child Adolesc Psychiatry. 2006;15(6):309–318. doi:10.1007/s00787-006-0534-7
   PubMed Web of Science ®Google Scholar